Intelliseq

About:

Intelliseq is a genome informatics company developing bioinformatics tools for diagnostics, therapy, and prevention based on genetic data.

Website: https://intelliseq.com/

Twitter/X: intelliseq

Top Investors: Google for Startups, Unfold.vc, Cobin Angels, YouNick Mint

Description:

Intelliseq is a genome informatics company developing bioinformatics tools for diagnostics, therapy, and prevention based on genetic data. Currently bioinformatics systems in laboratories are not ready for genomics at scale. The analysis process of already sequenced genomes is now mostly expensive and labor-intensive. In response to this problem the company created a cloud-based platform called IntelliseqFlow that allows for automated bioinformaticianless generation of result reports that accelerates the entire diagnostic process and reduces the costs that the laboratory had to deal with so far. IntelliseqFlow translates raw DNA data into final reports automatically, making the analysis step fast, simple, cost-effective and user-friendly. Allows users to choose ready-to-use workflows for PGx, Germline Disorders, Somatic Cancer, and Polygenic Risk Scoring all wrapped-up in one user-friendly platform. It comprises AI-based algorithms, easy to operate pipelines, customized workflows, and APIs that make it simple to integrate our engine with laboratory information systems. The company was established in 2014 by a group of scientists fascinated with pharmacogenomics and transcriptomics. Intelliseq’s products are currently being used by laboratories in Asia, Europe, and the US.